Literature DB >> 11329471

Elastase deficiency phenotype of Pseudomonas aeruginosa canine otitis externa isolates.

S R Petermann1, C Doetkott, L Rust.   

Abstract

Pseudomonas aeruginosa veterinary isolates were assayed for elastase and total matrix protease activity. The elastase activity of canine ear isolates was much less than that of strain PAO1 and that of all other veterinary isolates (P < 0.0001). The results indicate that canine ear isolates have a distinct elastase phenotype.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11329471      PMCID： PMC96114          DOI： 10.1128/CDLI.8.3.632-636.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


  30 in total

1.  Genetic recombination in Pseudomonas aeruginosa.

Authors:  B W HOLLOWAY
Journal:  J Gen Microbiol       Date:  1955-12

2.  Degradation of IgA proteins by Pseudomonas aeruginosa elastase.

Authors:  L W Heck; P G Alarcon; R M Kulhavy; K Morihara; M W Russell; J F Mestecky
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

3.  Proteolytic inactivation of cytokines by Pseudomonas aeruginosa.

Authors:  M Parmely; A Gale; M Clabaugh; R Horvat; W W Zhou
Journal:  Infect Immun       Date:  1990-09       Impact factor: 3.441

4.  Pseudomonas elastase acts as a virulence factor in burned hosts by Hageman factor-dependent activation of the host kinin cascade.

Authors:  I A Holder; A N Neely
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

5.  Utilization of human respiratory secretions by mucoid Pseudomonas aeruginosa of cystic fibrosis origin.

Authors:  D E Ohman; A M Chakrabarty
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

6.  Cloning and characterization of the Pseudomonas aeruginosa lasR gene, a transcriptional activator of elastase expression.

Authors:  M J Gambello; B H Iglewski
Journal:  J Bacteriol       Date:  1991-05       Impact factor: 3.490

7.  Elastase of Pseudomonas aeruginosa: inactivation of complement components and complement-derived chemotactic and phagocytic factors.

Authors:  D R Schultz; K D Miller
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

8.  Phenotypic comparison of Pseudomonas aeruginosa strains isolated from a variety of clinical sites.

Authors:  D E Woods; M S Schaffer; H R Rabin; G D Campbell; P A Sokol
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 11.677

9.  [Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections].

Authors:  G Döring
Journal:  Infection       Date:  1987 Jan-Feb       Impact factor: 7.455

10.  The contribution of exoproducts to virulence of Pseudomonas aeruginosa.

Authors:  T I Nicas; B H Iglewski
Journal:  Can J Microbiol       Date:  1985-04       Impact factor: 3.226
View more
  1 in total

1.  Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins.

Authors:  Gabriel Torrens; Isabel M Barceló; Marcelo Pérez-Gallego; Maria Escobar-Salom; Sara Tur-Gracia; Marta Munar-Bestard; María Del Mar González-Nicolau; Yoandy José Cabrera-Venegas; Estefany Nayarith Rigo-Rumbos; Gabriel Cabot; Carla López-Causapé; Estrella Rojo-Molinero; Antonio Oliver; Carlos Juan
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.